Literature DB >> 19665533

Development of a standardized dissolution test method for inhaled pharmaceutical formulations.

Yoen-Ju Son1, Jason T McConville.   

Abstract

The aim of this research was to investigate a potential standardized test method to characterize the dissolution properties of formulations intended for pulmonary delivery. A commercially available dissolution tester was adapted to be used as a testing apparatus by incorporation of a membrane containing cassette. The cassette was designed to enclose previously air-classified formulations, so that they could be uniformly tested in the dissolution apparatus. The influence of particle size, amount of drug loading, and the composition of a simulated lung fluid (SLF) dissolution media on the dissolution rate were studied. Dissolution rate was significantly affected by the uniformity of drug loading, and particle size. Diffusion coefficients, estimated using the Higuchi model, showed an increase from 2.28 to 9.60x10(-7) cm(2)/h as the particle size decreased. Addition of DPPC (0.02%, w/v) to the SLF dissolution media resulted also resulted in an increase in the diffusion coefficient value. This study demonstrated that the developed method was reproducible and may be used to evaluate the dissolution properties of pharmaceutical inhalation products following their aerodynamic particle classification.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665533     DOI: 10.1016/j.ijpharm.2009.07.034

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  20 in total

1.  Dissolution techniques for in vitro testing of dry powders for inhalation.

Authors:  Sabine May; Birte Jensen; Markus Wolkenhauer; Marc Schneider; Claus Michael Lehr
Journal:  Pharm Res       Date:  2012-04-20       Impact factor: 4.200

Review 2.  In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.

Authors:  Ben Forbes; Per Bäckman; David Christopher; Myrna Dolovich; Bing V Li; Beth Morgan
Journal:  AAPS J       Date:  2015-05-05       Impact factor: 4.009

3.  Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and India.

Authors:  Sau L Lee; Bhawana Saluja; Alfredo García-Arieta; Gustavo Mendes Lima Santos; Ying Li; Sarah Lu; Shuguang Hou; Juliet Rebello; Abhijit Vaidya; Jaideep Gogtay; Shrinivas Purandare; Svetlana Lyapustina
Journal:  AAPS J       Date:  2015-05-23       Impact factor: 4.009

4.  In Vivo-Relevant Transwell Dish-Based Dissolution Testing for Orally Inhaled Corticosteroid Products.

Authors:  Masahiro Sakagami; Hua Li; Jügen Venitz
Journal:  Pharm Res       Date:  2019-05-09       Impact factor: 4.200

Review 5.  Challenges with developing in vitro dissolution tests for orally inhaled products (OIPs).

Authors:  Trevor Riley; David Christopher; Jan Arp; Andrea Casazza; Agnes Colombani; Andrew Cooper; Monisha Dey; Janet Maas; Jolyon Mitchell; Maria Reiners; Nastaran Sigari; Terrence Tougas; Svetlana Lyapustina
Journal:  AAPS PharmSciTech       Date:  2012-07-14       Impact factor: 3.246

6.  Dissolution testing of powders for inhalation: influence of particle deposition and modeling of dissolution profiles.

Authors:  Sabine May; Birte Jensen; Claudius Weiler; Markus Wolkenhauer; Marc Schneider; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2014-05-23       Impact factor: 4.200

7.  Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2015-09-30       Impact factor: 2.897

8.  In vitro assessment of arsenic mobility in historical mine waste dust using simulated lung fluid.

Authors:  Rachael Martin; Kim Dowling; Scott Nankervis; Dora Pearce; Singarayer Florentine; Stafford McKnight
Journal:  Environ Geochem Health       Date:  2017-05-12       Impact factor: 4.609

9.  Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment.

Authors:  Nathalie Wauthoz; Philippe Deleuze; Amandine Saumet; Christophe Duret; Robert Kiss; Karim Amighi
Journal:  Pharm Res       Date:  2010-11-30       Impact factor: 4.200

10.  High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies.

Authors:  Samantha A Meenach; Kimberly W Anderson; J Zach Hilt; Ronald C McGarry; Heidi M Mansour
Journal:  AAPS PharmSciTech       Date:  2014-08-20       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.